title: Successful treatment of disseminated BCG in a patient with severe combined immunodeficiency.
authors.affiliation: Children's Hospital of the King's Daughters, Eastern Virginia School of Medicine, Norfolk, Va.
authors.forename: Lauren L
authors.initials: LL
authors.lastname: Smith
authors.affiliation: Fellow in Allergy and Clinical Immunology, Duke University Medical Center, Durham, NC.
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Wright
authors.affiliation: J. Buren Sidbury Professor of Pediatrics and Professor of Immunology, Duke University Medical Center, Durham, NC. Electronic address: rebecca.buckley@dm.duke.edu.
authors.forename: Rebecca H
authors.initials: RH
authors.lastname: Buckley
mesh_terms: D019264:Adoptive Transfer; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D008279:Magnetic Resonance Imaging; D009163:Mycobacterium bovis / Q000276:immunology / Q000472:pathogenicity*; D012307:Risk Factors; D016511:Severe Combined Immunodeficiency / Q000150:complications / Q000175:diagnosis / Q000276:immunology / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis / Q000276:immunology / Q000382:microbiology* / Q000628:therapy
chemical_list: D000995:Antitubercular Agents; D001500:BCG Vaccine